Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use of Hyaluronic Acid-enriched Transfer Medium in Women Undergoing Single Blastocyst Transfer
NCT06492785Recruiting
- Sponsor
- Northwest Women's and Children's Hospital
- Start
- Sep 2024
- Primary completion
- Dec 2025
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, triple-blind trial of hyaluronic acid in infertility (2 arms), sponsored by Northwest Women's and Children's Hospital. Primary endpoint: Live birth rate. Started Sep 2024; status: recruiting.
02
Drugs
hyaluronic acid
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06492785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06492785.